Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog

Journal of Veterinary Diagnostic Investigation

Volumn 16, Issue 6, 2004, Pages 554-561

  Preziosi, Rosario ^a   Morini, Maria ^a   Sarli, Giuseppe ^a  

^a Division of Veterinary Pathology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

EID: 8844269563     PISSN: 10406387     EISSN: None     Source Type: Journal    
DOI: 10.1177/104063870401600610     Document Type: Article

References (31)

1. Abadie JJ, Amardeilh MA, Deverdier ME: 1999, Immunohistochemical detection of proliferating cell nuclear antigen and Ki67 in mast cell tumors from dogs. J Am Vet Med Assoc 215:1629-1634.
2. Arber DA, Tamayo R, Weiss IM: 1998, Paraffin section detection of c-kit geneproduct (CD117) in human tissues. Value in the diagnosis of mast cell disorders. Hum Pathol 29:498-504.
3. Bostock DE: 1973, The prognosis following surgical removal of mastocytomas in dogs. J Small Anim Pract 14:27-41.
4. Bostock DE, Crocker J, Harris K, Smith P: 1989, Nucleolar organiser regions as indicators of postsurgical prognosis in canine spontaneous mast cell tumours. Br J Cancer 59:915-918.
5. Camussi A, Möller F, Ottaviano E, Sari Gorla M: 1991, Metodi Statistici per la sperimentazione biologica 4° ed. Edizioni Zanichelli, Bologna, Italy.
6. Furitsu T, Tsujimura T, Tono T, et al.: 1993, Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand independent activation of c-kit product. J Clin Investig 92:1736-1744.
7. Galli SJ, Zsebo KM, Geissler EN: 1994, The kit ligand, stem cell factor. Adv Immunol 55:1-96.
8. Gibson PC, Cooper K: 2002, CD117 (KIT): a diverse protein with selective applications in surgical pathology. Adv Anat Pathol 9:65-69.
9. Hirota S, Isozaki K, Moriyama Y, et al.: 1998, Gain of function mutation of c-kit in human gastrointestinal stromal tumors. Science 279:577-580.
10. London CA, Galli S, Yuuki T, et al.: 1999, Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit. Exp Hematol 27:689-697.
11. London CA, Kisseberth WC, Galli SJ, et al.: 1996, Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumours. J Comp Pathol 115:399-414.
12. Longley BJ, Tyrrel L, Lu SZ, et al.: 1996, Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet 12:312-314.
13. Ma Y, Longley BJ, Wang X, et al.: 1999, Clustering of activating mutations in c-KIT's juxtamembrane coding region in canine mast cell neoplasms. J Investig Dermatol 112:165-170.
14. Macy DW: 1984, Canine and feline mast cell tumours: biologic behavior, diagnosis and therapy. Semin Vet Med Surg 1:72-83.
15. Nagata H, Worobec AS, Semere T, Metcalfe DD: 1998, Elevated expression of the proto-oncogene c-kit in patients with mastocytosis. Leukemia 12:175-181.
16. Ozaki K, Yamagami T, Nomura K, Narama I: 2002, Mast cell tumors of the gastrointestinal tract in 39 dogs. Vet Pathol 39:557-564.
17. Patnaik AK, Ehler WY, MacEwen EG: 1984, Canine cutaneous mast cell tumors: morphologic grading and survival time in 83 dogs. Vet Pathol 21:469-474.
18. Qiu F, Ray P, Brown K, et al.: 1988, Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family-oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J 7:1003-1011.
19. Reguera MJ, Ferrer L, Rabanal RM: 2002, Evaluation of an intron deletion in the c-kit gene of canine mast cell tumors. Am J Vet Res 63:1257-1261.
20. Reguera MJ, Rabanal RM, Puigdemont A, Ferrer L: 2000, Canine mast cell tumors express stem cell factor receptor. Am J Dermatopathol 22(1):49-54.
21. Séguin B, Leibman NF, Bregazzi SV, et al.: 2001, Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999). J Am Vet Med Assoc 218:1120-1123.
22. Simoes JPC, Schoning P, Butine M: 1994, Prognosis of canine mast cell tumors: a comparison of three methods. Vet Pathol 31:637-647.
23. Takahashi T, Kadosawa T, Nagase M, et al.: 2000, Visceral mast cell tumors in dogs: 10 cases (1982-1997). J Am Vet Med Assoc 216:222-226.
24. Tsai M, Takeishi T, Thompson H, et al.: 1991, Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci USA 88:6382-6386.
25. Tsujimura T, Furitsu T, Morimoto M, et al.: 1994, Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood 83:2619-2626.
26. Tsujimura T, Furitsu T, Morimoto M, et al.: 1995, Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3. Int Arch Allergy Immunol 106:377-385.
27. Vail DM: 1996, Mast cell tumors. In: Small animal clinical oncology, ed. Withrow SJ, Mac Ewen EG, pp. 192-210, WB Saunders, Philadelphia, PA.
28. Walder EJ, Gross TL: 1992, Canine mast cell tumors. In: Veterinary dermatopathology - a macroscopic and microscopic evaluation of canine and feline skin disease, ed. Gross TL, Ihrke PJ, Walder EJ, pp. 470-473, Mosby Year Book Inc, St. Louis, MO.
29. Yarden Y, Kuang WJ, Yang-Feng T, et al.: 1987, Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341-3351.
30. Zemke D, Yamini B, Yuzbasiyan-Gurkan V: 2001, Characterization of an undifferentiated malignancy as a mast cell tumor using mutation analysis in the proto-oncogene c-KIT. J Vet Diagn Invest 13:341-345.
31. Zemke D, Yamini B, Yuzbasiyan-Gurkan V: 2002, Mutations in the juxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs. Vet Pathol 39:529-535.